HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

C&D Steps Up To The Plate; Signs Baseball Star Giambi To Promote Ultramax

This article was originally published in The Rose Sheet

Executive Summary

Church & Dwight has signed New York Yankees baseball player Jason Giambi as spokesperson for its Arm & Hammer Ultramax antiperspirant/deodorant brand, Personal Care and Armkel President Brad Casper said

You may also be interested in...



Nair Depilatories Brand Upgraded With New Products And Packaging

Church & Dwight is upgrading its line of Nair depilatories with new products, more efficacious formulas and modern packaging, the company announced during the recent National Association of Chain Drug Stores Marketplace conference

Nair Depilatories Brand Upgraded With New Products And Packaging

Church & Dwight is upgrading its line of Nair depilatories with new products, more efficacious formulas and modern packaging, the company announced during the recent National Association of Chain Drug Stores Marketplace conference

C&D Organic Growth Initiative To Sprout Oral Care, Antiperspirant Extensions

Church & Dwight is undertaking an aggressive product launch strategy within its oral care and antiperspirant/ deodorant businesses in 2003 as it shifts its focus to internal growth, CEO Robert Davies told analysts during a third quarter financials briefing Nov. 4

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010385

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel